New Perspectives on Atherogenesis

Open Access
Publisher Website
Google Scholar
Abstract
Therosclerosis, along with the resultant coronary artery disease (CAD), is a leading cause of mortality in industrialized countries. Significant attention has focused on the role of low-density lipoprotein (LDL) in the pathogenesis of CAD. A dyslipidemia characterized by a combination of abnormalities in the plasma levels of triglycerides and high- density lipoprotein (HDL) cholesterol, with or without ele- vated LDL cholesterol levels, affects many persons with premature CAD, however. In particular, both qualitative and quantitative abnormalities in circulating triglyceride-rich li- poproteins (TRLPs) may be a key factor in the development of CAD.1 A number of advances have led to an increased apprecia- tion of TRLP concentrations as independent predictors of risk for CAD. First, the meta-analysis by Hokanson and Austin2 demonstrated that increases in plasma triglyceride levels were associated with increased risk for CAD events, even after adjusting for numerous other predictive factors. The meta- analysis was supported by a more recent prospective study by Jeppesen et al,3 which demonstrated that triglyceride levels were independent predictors of ischemic heart disease in men. Second, a number of studies have demonstrated that TRLPs, whether assembled in and secreted from the intestine or the liver, can penetrate the artery wall and initiate or aggravate atherogenesis. Third, during the last decade, we have gained a much more detailed understanding of the metabolic rela- tionship between high levels of TRLPs, low levels of high- density lipoprotein (HDL) cholesterol, and an abnormally small, cholesterol-depleted, dense LDL.4 This review will attempt to bring together information from recent cellular, biochemical, physiological, and molecular studies to provide an update of our understanding of both normal and abnormal TRLP metabolism and of the atherogenicity of TRLPs.

This publication has 63 references indexed in Scilit: